Tetrahydroaminacrine en es it fr

Tetrahydroaminacrine Brand names, Tetrahydroaminacrine Analogs

Tetrahydroaminacrine Brand Names Mixture

  • No information avaliable

Tetrahydroaminacrine Chemical_Formula


Tetrahydroaminacrine RX_link


Tetrahydroaminacrine fda sheet

Tetrahydroaminacrine msds (material safety sheet)

Tetrahydroaminacrine MSDS

Tetrahydroaminacrine Synthesis Reference

No information avaliable

Tetrahydroaminacrine Molecular Weight

198.264 g/mol

Tetrahydroaminacrine Melting Point

183.5 oC

Tetrahydroaminacrine H2O Solubility

217 mg/L

Tetrahydroaminacrine State


Tetrahydroaminacrine LogP


Tetrahydroaminacrine Dosage Forms

No information avaliable

Tetrahydroaminacrine Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Tetrahydroaminacrine Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Tetrahydroaminacrine Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Tetrahydroaminacrine side effects and Toxicity

No information avaliable

Tetrahydroaminacrine Patient Information

No information avaliable

Tetrahydroaminacrine Organisms Affected

Humans and other mammals